In knock­out IPO of­fer­ings, Mor­phoSys and Sur­face On­col­o­gy haul com­bined $316M in up­sized deals

Two biotechs new to Nas­daq sparked more in­vestor in­ter­est than orig­i­nal­ly ex­pect­ed Wednes­day, haul­ing up­sized IPOs that are yet an­oth­er in­di­ca­tion of the in­dus­try’s rip …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER